Search Results - "Ghonem, Nisanne S."

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Fibrates and cholestasis by Ghonem, Nisanne S., Assis, David N., Boyer, James L.

    Published in Hepatology (Baltimore, Md.) (01-08-2015)
    “…Cholestasis, including primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC), results from an impairment or disruption of bile production…”
    Get full text
    Journal Article
  2. 2

    Treprostinil alleviates hepatic mitochondrial injury during rat renal ischemia-reperfusion injury by Hou, Joyce, Tolbert, Evelyn, Birkenbach, Mark, Ghonem, Nisanne S.

    Published in Biomedicine & pharmacotherapy (01-11-2021)
    “…Renal ischemia-reperfusion injury (IRI) causes acute kidney injury as well as liver injury. Renal IRI depletes hepatic antioxidants, promotes hepatic…”
    Get full text
    Journal Article
  3. 3

    Treprostinil reduces mitochondrial injury during rat renal ischemia-reperfusion injury by Ding, Meiwen, Tolbert, Evelyn, Birkenbach, Mark, Gohh, Reginald, Akhlaghi, Fatemeh, Ghonem, Nisanne S.

    Published in Biomedicine & pharmacotherapy (01-09-2021)
    “…Renal ischemia-reperfusion injury (IRI) is a major factor contributing to acute kidney injury and it is associated with a high morbidity and mortality if…”
    Get full text
    Journal Article
  4. 4
  5. 5

    PPAR-Mediated Bile Acid Glucuronidation: Therapeutic Targets for the Treatment of Cholestatic Liver Diseases by Gallucci, Gina M, Hayes, Colleen M, Boyer, James L, Barbier, Olivier, Assis, David N, Ghonem, Nisanne S

    Published in Cells (Basel, Switzerland) (01-08-2024)
    “…Cholestatic liver diseases, including primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC), result from an impairment of bile flow that…”
    Get full text
    Journal Article
  6. 6

    Adjunct Fenofibrate Up‐regulates Bile Acid Glucuronidation and Improves Treatment Response For Patients With Cholestasis by Gallucci, Gina M., Trottier, Jocelyn, Hemme, Christopher, Assis, David N., Boyer, James L., Barbier, Olivier, Ghonem, Nisanne S.

    Published in Hepatology communications (01-12-2021)
    “…Accumulation of cytotoxic bile acids (BAs) during cholestasis can result in liver failure. Glucuronidation, a phase II metabolism pathway responsible for BA…”
    Get full text
    Journal Article
  7. 7

    Treprostinil, a prostacyclin analog, ameliorates renal ischemia-reperfusion injury: preclinical studies in a rat model of acute kidney injury by Ding, Meiwen, Tolbert, Evelyn, Birkenbach, Mark, Akhlaghi, Fatemeh, Gohh, Reginald, Ghonem, Nisanne S

    Published in Nephrology, dialysis, transplantation (25-01-2021)
    “…Renal ischemia-reperfusion injury (IRI) is a major factor causing acute kidney injury (AKI). No pharmacological treatments for prevention or amelioration of…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Fenofibrate Downregulates NF-κB Signaling to Inhibit Pro-inflammatory Cytokine Secretion in Human THP-1 Macrophages and During Primary Biliary Cholangitis by Gallucci, Gina M., Alsuwayt, Bader, Auclair, Adam M., Boyer, James L., Assis, David N., Ghonem, Nisanne S.

    Published in Inflammation (01-12-2022)
    “…Chronic liver diseases, e.g., cholestasis, are negatively impacted by inflammation, which further aggravates liver injury. Pharmacotherapy targeting the…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    On Fibrates and Cholestasis: A review by Ghonem, Nisanne S., Assis, David N., Boyer, James L.

    Published in Hepatology (Baltimore, Md.) (23-03-2015)
    “…Cholestasis, including primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC), results from an impairment or disruption of bile production…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Treprostinil for protection of liver grafts against ischemia and reperfusion injury during orthotopic liver transplantation - A translational study by Ghonem, Nisanne S

    Published 01-01-2010
    “…Orthotopic liver transplantation (OLT) is the only curative therapy for end-stage liver diseases. To overcome organ shortage, organs from extended criteria…”
    Get full text
    Dissertation